Can votrient cure cancer?

Votrient is not a cure for cancer, but it does increase progression-free survival – this is the length of time during and after treatment that a patient lives with the disease but it does not get worse – and can shrink or slow the growth of kidney cancer in some people.

Does votrient shrink tumors?

Votrient has been shown to slow the growth and spread of renal cell carcinoma and soft tissue sarcoma. (Renal cell carcinoma is a type of kidney cancer. Soft tissue sarcoma is cancer of the soft tissue, such as muscles, tendons, nerves, and blood vessels.) Votrient may also help shrink these types of tumors.

Is votrient chemotherapy?

Votrient is not a chemotherapy drug but one of many “targeted therapies.” Targeted therapy is the result of about 100 years of research dedicated to understanding the differences between cancer cells and normal cells.

What type of drug is Votrient?

VOTRIENT® (pazopanib) tablets is a prescription medicine used to treat adults with advanced renal cell cancer (RCC). VOTRIENT is a prescription medicine used to treat adults with advanced soft tissue sarcoma (STS) who have received chemotherapy in the past.

How fast does Votrient work?

by Drugs.com This means it takes anywhere from 124 to 155 hours for Votrient to leave your body. Votrient is an oral tablet that is taken once daily to treat adults with soft tissue sarcoma who have received prior chemotherapy or advanced renal cell carcinoma.

When do you stop Votrient?

Your doctor may tell you to temporarily stop treatment with this medication at least 1 week before surgery. Ask your doctor for specific instructions about when to stop and when to restart treatment with pazopanib. Tell your doctor right away if you have wounds that are not healing well.

How long can you stay on pazopanib?

The median time on pazopanib in these patients was 2.4 years with the longest duration of 3.7 years.